Hear from Nico Reynders, General Manager at UCB UK & Ireland and Vice Chair of the European Medicines Group. Nico champions patient-focused solutions and policy change for rare diseases.
Sign up free: https://bit.ly/RR-UCB-Webinar
#Pharma #PolicyChange #RareDisease #RARERevinar

Dr Charlotte Roy from Muscular Dystrophy UK is joining our panel! With a background in molecular biology and advocacy, Charlotte brings both expertise and empathy to the rare disease conversation.
Register: https://bit.ly/RR-UCB-Webinar
#MuscularDystrophy #PatientAdvocacy #RareDisease #RARERevinar

We’re excited to welcome Sheela Upadhyaya, former Associate Director at NICE and rare disease policy expert. Sheela will share invaluable perspectives on HTA and patient access.
Join us: https://bit.ly/RR-UCB-Webinar
#HTA #NICE #RareDisease #RARERevinar

How can collaboration between healthcare and industry transform access for rare disease patients?
Find out at our upcoming RARE REV-inar, featuring expert panellists and real-world insights.
Register now: https://bit.ly/RR-UCB-Webinar
#RareDisease #Pharma #HTA #PatientAdvocacy #RARERevinar

Meet Kylie Bromley, General Manager of Biogen UK and Chair of the BIA’s Rare Disease Industry Group. Kylie brings deep expertise in rare disease strategy and policy. Hear her insights at RARE REV-inar 023!
Sign up: https://bit.ly/RR-UCB-Webinar
#RareDisease #PharmaLeadership #RARERevinar

Join us for our next RARE REV-inar: “Strengthening coordination between the health system and industry to improve patient access.”
🗓️ Thursday 27th November 2025, 12pm GMT
🔗 Sign up: https://bit.ly/RR-UCB-Webinar
#RareDisease #PatientAccess #HealthcareInnovation #RARERevinar